How vaccines for younger children could boost economic recovery

Pfizer announced today that a smaller dose of its COVID-19 vaccine is proving safe and effective for children ages 5 to 11. If FDA emergency approval goes as planned, kids could be getting their shots by Halloween. This could, among other things, help moms get back to work. And later: how the weather affects what we buy; an Afghan American humanitarian reflects on the recent upheaval; and a look at what corporate pledges actually accomplish.